Preliminary Multicenter Experience With the Versius Robotic Surgical System for Radical Prostatectomy: Oncological Outcomes With a Minimum 18-Month of Follow-Up.

Iacopo Meneghetti¹, Francesco Dibitetto², Alberto Mariotti¹, Riccardo Morganti³, Justin Collins^4,5,6, Paola Pacetti⁷, Alessandra Corsini⁸, Luca Mosillo¹, Simone Belli¹, Roberto Boni⁹, Giulia Puccini⁹, Angelo Territo¹⁰, Muhammet Irfan Dönmez¹¹, Maria Chiara Sighinolfi¹², Bernardo Rocco¹², Mauro De Dominicis², Luca Morelli¹³, Maurizio De Maria¹

¹Department of Urology, Apuane Hospital, Massa, Italy.

²Department of Urology, Uroclinic Casa di Cura Nuova Villa Claudia, Rome, Italy.

³Clinical Trial Statistical Support Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.

⁴Division of Surgery and Interventional Science, Research Department of Targeted Intervention, University College London, London, UK.

⁵Division of Uro-oncology, University College London Hospital, London, UK.

⁶Associate Medical Director CMR Surgical, Cambridge, UK.

⁷Medical Oncology Unit, Apuane Hospital, Massa, Italy.

⁸Radiation Oncology, Apuane Hospital, Massa, Italy.

⁹Nuclear Medicine, Apuane Hospital, Massa, Italy.

¹⁰Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.

¹¹Division of Pediatric Urology, Department of Urology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey.

¹²Department of Urology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

¹³General Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

PubMed DOI

Abstract

OBJECTIVE: To report the minimum 18-month follow-up oncological results of the first preliminary descriptive series of robot-assisted radical prostatectomy (RARP) using Versius Robotic Surgical System (VRSS). MATERIAL AND METHODS: Data of patients were collected from two Italian centres. Data on demographic variables, surgical results, pre- and postoperative prostatic specific antigen (PSA), need…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.